What happens to the rate of RBC production in a patient on dialysis with total renal failure? What could be given to the patient to counteract such a problem?

검증된 단계별 안내

Understand the role of the kidneys in red blood cell (RBC) production: The kidneys produce erythropoietin, a hormone that stimulates the bone marrow to produce RBCs. In total renal failure, the kidneys lose their ability to produce erythropoietin, leading to decreased RBC production and anemia.

Recognize the impact of dialysis: Dialysis replaces the filtration function of the kidneys but does not restore their ability to produce erythropoietin. Therefore, patients on dialysis with total renal failure often experience chronic anemia due to insufficient erythropoietin production.

Identify the treatment for anemia caused by renal failure: To counteract the lack of erythropoietin, synthetic erythropoietin (e.g., erythropoiesis-stimulating agents like epoetin alfa) can be administered to stimulate RBC production in the bone marrow.

Consider additional supportive measures: Patients may also require iron supplementation, as iron is a critical component of hemoglobin in RBCs. Iron deficiency can further impair RBC production, so ensuring adequate iron levels is essential.

Review Table 9.2 for further details: Table 9.2 likely provides information on erythropoiesis-stimulating agents, their mechanism of action, and their role in managing anemia in patients with renal failure. Use this table to deepen your understanding of the treatment options.

비슷한 문제에 대한 검증된 영상 답변:

이 영상 해법은 위 문제에 도움이 된다고 튜터들이 추천한 것입니다.

영상 길이:

주요 개념

질문에 올바르게 답하기 위해 반드시 이해해야 하는 핵심 개념들은 다음과 같습니다.

Renal Failure and Erythropoiesis

Renal failure significantly impacts erythropoiesis, the process of red blood cell (RBC) production. The kidneys produce erythropoietin (EPO), a hormone that stimulates RBC production in the bone marrow. In total renal failure, EPO production is severely diminished, leading to decreased RBC production and potentially resulting in anemia.

Dialysis and Its Effects

Dialysis is a medical treatment that performs the functions of the kidneys, including the removal of waste products and excess fluids from the blood. However, it does not replace the hormonal functions of the kidneys, such as EPO production. As a result, patients on dialysis often experience anemia due to the lack of adequate RBC production.

Erythropoietin Therapy

Erythropoietin therapy involves administering synthetic EPO to patients with anemia, particularly those with chronic kidney disease or on dialysis. This treatment stimulates the bone marrow to increase RBC production, helping to counteract anemia and improve the patient's overall health and energy levels.